Abstract Glucagon-like peptide-1 Receptor agonists (GLP-1Ras) such as liraglutide and semaglutide have been recently approved as medications for chronic weight management in people living with obesity (PwO)
ACCORDING TO THIS STUDY , SUPPORTED BY THE NATIONAL INSTITUTE OF HEALTH AND THE US DEPARTMENT OF AGRICULTURAL RESEARCH SERVICE, WHICH ANALYZED VITAMIN B12 CONCENTRATIONS IN 3000 SUBJECTS AGED 26-83 YEARS OLD EVEN THOUGH A BALANCED DIET OF VARIOUS FOOD SOURCES LIKE FORTIFIED CEREALS, DAIRY, MEAT, WAS CONSUMED 39% OF INDIVIDUALS TESTED WITH LOWER THAN RECOMMENDED B12 LEVELS
Shanti Mulling: for an endometrioma
LHRH and LHR genotypes and prostate cancer incidence and survival
A 2026 systematic review and meta-analysis in Clinical Endocrinology pooled 5 randomized controlled trials of short-term, low-dose spironolactone in PCOS hyperandrogenic symptoms and found a meaningful reduction in modified Ferriman-Gallwey hirsutism scores compared to placebo or alternative anti-androgens
Removals require formal step therapy or prior authorisation
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
